BSAC Spring
Conference 2026

14-15 May 2026, QEII Centre, London & online

Advancing Infection Management -
From Global Challenges to Clinical Innovation

Cutting-edge research and innovation

Antimicrobial resistance is the greatest healthcare challenge of our time—be part of the solution.

Stay up to date with the latest discoveries in antimicrobial resistance, emerging treatments, and cutting-edge research presented by leading experts.

Programme and registration details below.

This conference is RCPath CPD approved (11 credits).

Presentations from previous conferences are available in the conference archive area.

The BSAC Spring Conference is supported by the pharmaceutical industry through sponsorship and exhibition packages. Sponsorship is restricted to the purchase of exhibition space and sponsored sessions. Sponsors have had no influence over the development of the scientific programme, including the selection of speakers or meeting content.

Any sessions developed with sponsor input will be clearly identified within the programme. A full list of confirmed sponsors for the BSAC Spring Conference is available here.

Programme

0845
0945
1415
1045
0345
Registration & coffee
0945
1045
1515
1145
0445
Welcome and opening remarks
Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
SESSION ONE - What's new?
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde - View Bio
0950
1050
1520
1150
0450
De-linkage - making sense of the subscription model
Sophie Cooper, National Institute for Health and Care Excellence - View Bio
1010
1110
1540
1210
0510
Novel antimicrobial strategies in management of diabetic foot
Professor Michael Edmonds, Kings College Hospital - View Bio
1030
1130
1600
1230
0530
Beyond the bedside: The rising role of nurses as champions of stewardship
Laura Ahearn, Northern Care Alliance NHS Foundation Trust - View Bio
1050
1150
1620
1250
0550
Q&A
1105
1205
1635
1305
0605
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION TWO - Microbes, money, and power: The political economy of infection
Chair: Dr Louise Sweeney, Manchester University NHS Foundation Trust - View Bio
1135
1235
1705
1335
0635
Sustainable capitalism and antimicrobial effectiveness
Professor Adam Dixon, Adam Smith’s Panmure House - View Bio
1155
1255
1725
1355
0655
The price of protection: Financing infection control in an unequal world
Dr Koen Pouwels, University of Oxford - View Bio
1215
1315
1745
1415
0715
Q&A
SESSION THREE - Infection in immunocompromised patients
Chair: Dr David Jenkins, University Hospital Leicester & Immediate Past President, BSAC - View Bio
1230
1330
1800
1430
0730
Managing infections in stem cell transplant recipients
Professor David van Duin, Editor-in-Chief, JAC-AMR & Professor of Medicine, University of North Carolina - View Bio
1300
1400
1830
1500
0800
Q&A
1310
1410
1840
1510
0810
LUNCH BREAK EXHIBITION & POSTER VIEWING
SESSION FOUR - SUPPORTED SESSION
Chair: Professor Sir Jonathan Van-Tam MBE, Formerly, Deputy Chief Medical Officer, Department of Health & Social Care, England - View Bio
Supported by: GSK
1350
1450
1920
1550
0850
Fireside chat: Vaccines, Therapeutics and Innovation: A Whole-Pathway Approach to AMR
Dr Malick Gibani, Imperial College London - View Bio
Ms Sarah Cavanagh, Public Health Pharmacist, NHS England - View Bio
SESSION FIVE - Garrod lecture
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow & Clyde and BSAC President - View Bio
1425
1525
1955
1625
0925
Antimicrobials from bench to bedside and beyond
Dr J Peter Donnelly, former Editor in Chief, Journal of Antimicrobial Chemotherapy - View Bio
1510
1610
2040
1710
1010
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION SIX - Fungal infections: Global epidemiology & new agents
Chair: Fran Garraghan, BSAC - View Bio
1540
1640
2110
1740
1040
Global burden of fungal disease: Epidemiology, trends & emerging threats
Professor David Denning, University of Manchester - View Bio
1600
1700
2130
1800
1100
Aspergillus and COPD: A Growing Concern
Professor Tom Rogers, Emeritus Professor, Trinity College Dublin - View Bio
1620
1720
2150
1820
1120
New antifungal agents & the future pipeline
Netta Tyler, Royal Papworth Hospital NHS Foundation Trust - View Bio
1640
1740
2210
1840
1140
Q&A
SESSION SEVEN - Invited papers supported by JAC and JAC-AMR
Chair: Dr Elda Righi, Guy's and St Thomas' NHS Foundation Trust & Associate Editor, JAC-AMR - View Bio
1655
1755
2225
1855
1155
Advancing Antimicrobial Stewardship Through Data Innovation: A Virtual Registry for Newly Licensed Antimicrobial Agents in Scotland (UKAR: Virtual)
Dr Amanj Kurdi, University of Strathclyde
1710
1810
2240
1910
1210
Superbug Showdown: Data vs. Microbes
Dr Helen Callaby, University of Dundee
1725
1825
2255
1925
1225
Hospitalised patients’ perspectives on Antimicrobial Resistance and Stewardship: A mixed-methods study across six clinical groups
Benson Jacob, Royal College of Surgeons Ireland
1740
1840
2310
1940
1240
Q&A
1750
1850
2320
1950
1250
End of day 1 closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio
0830
0930
1400
1030
0330
Registration & coffee
SESSION EIGHT - Antimicrobial stewardship - invited papers
Chair: Dr Ioannis Baltas, ST5 Infectious Diseases & Medical Microbiology, London Deanery & NIHR Academic Clinical Fellow in Infectious Diseases, University College London - View Bio
0850
0950
1420
1050
0350
Consumption of Colistin and Fosfomycin in a Burn Intensive Care Unit
Dr Nesrine Hagui, Trauma and Major Burns Center, Tunisia - View Bio
0905
1005
1435
1105
0405
A qualitative exploration of the perceptions of stakeholders involved in the implementation of Antimicrobial Stewardship policy in Ireland
Dr Aoife Fleming, University College Cork
0920
1020
1450
1120
0420
Parental preferences for primary care pathways in respiratory infections: a discrete choice experiment
Anthony Maher, University of Galway
0935
1035
1505
1135
0435
Q&A
SESSION NINE - Invited lectures
Chair: Professor Paul Long, Kings College London - View Bio
0950
1050
1520
1150
0450
Unequal care, unequal outcomes: Addressing disparities in infection management
Professor Diane Ashiru-Oredope, UKHSA - View Bio
1010
1110
1540
1210
0510
Companion animals and AMR - a rising public health risk
Professor Dorina Timofte, University of Liverpool - View Bio
1030
1130
1600
1230
0530
Rewriting the rules of UTI: From misbehaving microbes to antibiotic alternatives
Professor Jenny Rohn, University College London - View Bio
1050
1150
1620
1250
0550
Q&A
1105
1205
1635
1305
0605
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION TEN - Fireside chat
Chair: Maggie Throup OBE - View Bio
1130
1230
1700
1330
0630
How can we close the gap and bring advanced infection diagnostics to the bedside?
Panellists:
Professor Gail Hayward, University of Oxford - View Bio
Dr Kerrie Davies MBE, Leeds Teaching Hospitals NHS Trust & University of Leeds - View Bio
Dr Rebecca Glover, LSHTM - View Bio
SESSION ELEVEN - SUPPORTED SESSIONS
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde - View Bio
1220
1320
1750
1420
0720
Part 1 - Facing the challenge of MBL Producing CPEs: A Pharmacist’s Real World Perspective
Stuart Brown, County Durham & Darlington NHS Foundation Trust - View Bio

Supported by: Pfizer Ltd
This promotional presentation is organised and funded by Pfizer Ltd and is intended for UK healthcare professionals only.
1235
1335
1805
1435
0735
Part 2 - Treatment decisions in intra-abdominal candidiasis: a case-based perspective
Ahmad Simreekheea, The Royal Marsden NHS Foundation Trust - View Bio
Supported by: NAPP
SESSION TWELVE - Communicating AMR: how to engage people and win support
Chair: Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde - View Bio
1255
1355
1825
1455
0755
Communicating AMR – challenges, opportunities, and YOUR role
Liz Callegari, Black Sands Communications Ltd - View Bio
1310
1410
1840
1510
0810
LUNCH BREAK EXHIBITION & POSTER VIEWING
SESSION THIRTEEN - SUPPORTED SESSION
Chair: Dr John Cunniffe, Countess of Chester NHS Foundation Trust
Supported by: InfectoPharm (UK) Ltd
1350
1450
1920
1550
0850
Beyond the MIC: Integrating Susceptibility Testing and Clinical Judgement to Combat AMR
Dr Julie Samuel, Newcastle upon Tyne Hospitals NHS Foundation Trust
SESSION FOURTEEN - Neonatal sepsis
Chair: Dr Alicia Demirjian, UK Health Security Agency - View Bio
1410
1510
1940
1610
0910
Global burden and epidemiology of neonatal sepsis
Dr Abhi Das, University College Hospital London
1435
1535
2005
1635
0935
Antimicrobial stewardship and challenges in LMIC settings
Dr Sose Margaryan, Wigmore Women’s & Children’s Hospital, Armenia - View Bio
1500
1600
2030
1700
1000
Q&A
SESSION FIFTEEN - Debate: This house believes that MICs are of minimal interest to clinicians
Chair: Dr Robin Howe, Public Health Wales - View Bio
1515
1615
2045
1715
1015
For
Professor Timothy Walsh, University of Oxford - View Bio
1525
1625
2055
1725
1025
Against
Dr Nick Brown, Cambridge University Hospitals NHS Trust - View Bio
1535
1635
2105
1735
1035
Discussion and Q&A
1600
1700
2130
1800
1100
Closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases & General Medicine, NHS Greater Glasgow and Clyde & President, BSAC - View Bio

Registration

If you missed the live event, you can still register to watch the recorded content from this hybrid conference which was held in London and online.

This conference is RCPath CPD accredited (11 credits).

For all enquiries, please contact Esme Carruthers

Please use the registration link below to register.

BSAC membership is free. If you are not already a member, we would be delighted if you could join us – you can JOIN HERE

For all enquiries, please contact Esme Carruthers

 

On demand registration (recorded content) £80

Register

Abstracts

Abstract submission

Submission is now closed

Sponsors

There are various exhibition and sponsorship opportunities available at this conference, please contact Esme Carruthers for further details.

Equality, Diversity & Inclusion

This conference celebrates diversity across gender, discipline, and career stage, featuring leading clinicians, researchers, and behavioural scientists. Sessions explore equitable access to vaccines, AMR stewardship, and the social determinants of health, while highlighting the role of multidisciplinary approaches in addressing global challenges. The programme ensures diverse voices shape both scientific discussion and policy insights.

© 2026, British Society for Antimicrobial Chemotherapy. All Rights Reserved.

53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118

Top